National Healthcare Properties, Inc.
HLTC
$8.20
$2.8653.53%
| Weiss Ratings | HLTC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | HLTC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HLTC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 3.90 | |||
| Price History | HLTC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 6.49% | |||
| 60-Day Total Return | 345.65% | |||
| 90-Day Total Return | 17.14% | |||
| Year to Date Total Return | 2.24% | |||
| 1-Year Total Return | -21.15% | |||
| 2-Year Total Return | -71.02% | |||
| 3-Year Total Return | -62.93% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -74.72% | |||
| 52-Week Low % Change | 379.53% | |||
| Price | HLTC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $32.44 | |||
| 52-Week Low Price | $1.71 | |||
| 52-Week Low Price (Date) | Oct 22, 2024 | |||
| 52-Week High Price (Date) | Oct 03, 2024 | |||
| Valuation | HLTC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 232.03M | |||
| Enterprise Value | 1.35B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -7.19 | |||
| Earnings Per Share Growth | 136.25% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.66 | |||
| Price/Book (Q) | 0.34 | |||
| Enterprise Value/Revenue (TTM) | 3.82 | |||
| Price | $8.20 | |||
| Enterprise Value/EBITDA (TTM) | 16.57 | |||
| Enterprise Value/EBIT | -1,254.53 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | HLTC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 28.30M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -7.27% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HLTC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 332 258 8770 | |||
| Address | 540 Madison Avenue New York, NY 10022 | |||
| Website | www.nhpreit.com | |||
| Country | United States | |||
| Year Founded | 2012 | |||
| Profitability | HLTC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -0.30% | |||
| Profit Margin | -53.61% | |||
| Management Effectiveness | HLTC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -0.03% | |||
| Return on Equity | -- | |||
| Income Statement | HLTC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 353.79M | |||
| Total Revenue (TTM) | 353.79M | |||
| Revenue Per Share | $12.50 | |||
| Gross Profit (TTM) | 105.03M | |||
| EBITDA (TTM) | 81.56M | |||
| EBIT (TTM) | -1.08M | |||
| Net Income (TTM) | -189.70M | |||
| Net Income Avl. to Common (TTM) | -203.50M | |||
| Total Revenue Growth (Q YOY) | 1.10% | |||
| Earnings Growth (Q YOY) | 31.50% | |||
| EPS Diluted (TTM) | -7.19 | |||
| EPS Diluted Growth (Q YOY) | 27.70% | |||
| Balance Sheet | HLTC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 40.86M | |||
| Cash Per Share (Q) | $1.44 | |||
| Total Current Assets (Q) | 156.18M | |||
| Total Preferred Equity (Q) | 0.08 | |||
| Total Equity (Q) | 690.13M | |||
| Current Ratio (Q) | 1.755 | |||
| Book Value Per Share (Q) | $24.19 | |||
| Total Assets (Q) | 1.95B | |||
| Total Current Liabilities (Q) | 88.99M | |||
| Total Debt (Q) | 1.15B | |||
| Total Liabilities (Q) | 1.26B | |||
| Total Common Equity (Q) | 684.48M | |||
| Cash Flow | HLTC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 63.97M | |||
| Cash from Financing (TTM) | -1.35M | |||
| Net Change in Cash (TTM) | -17.22M | |||
| Levered Free Cash Flow (TTM) | 53.32M | |||
| Cash from Operations (TTM) | -79.85M | |||
